The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer

被引：6

作者：

Gyftopoulos, Argyrios ^{[1
]}

Ziogas, Ioannis A. ^{[2
]}

Barbas, Andrew S. ^{[3
]}

Moris, Dimitrios ^{[3
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Med Sch, Athens, Greece

[2] Vanderbilt Univ Sch Med, Dept Surg, Div Hepatobiliary Surg & Liver Transplantat, Nashville, TN USA

[3] Duke Univ Med Ctr, Dept Surg, Durham, NC 27710 USA

来源：

FRONTIERS IN ONCOLOGY | 2022年 / 12卷

关键词：

irreversible electroporation; locally advanced pancreatic cancer; chemotherapy; electrochemotherapy; electrogene; immunotherapy; ADJUVANT CHEMOTHERAPY; GEMCITABINE; SURVIVAL; RESECTION; THERAPY; SAFETY; ELECTROCHEMOTHERAPY; ADENOCARCINOMA; FEASIBILITY; MANAGEMENT;

D O I：

10.3389/fonc.2022.843769

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Irreversible electroporation (IRE) is a local ablative technique used in conjunction with chemotherapy to treat locally advanced pancreatic cancer (LAPC). The combination of IRE and chemotherapy has showed increased overall survival when compared to chemotherapy alone, pointing towards a possible facilitating effect of IRE on chemotherapeutic drug action and delivery. This review aims to present current chemotherapeutic regimens for LAPC and their co-implementation with IRE, with an emphasis on possible molecular augmentative mechanisms of drug delivery and action. Moreover, the potentiating mechanism of IRE on immunotherapy, M1 oncolytic virus and dendritic cell (DC)-based treatments is briefly explored. Investigating the synergistic effect of IRE on currently established treatment regimens as well as newer ones, may present exciting new possibilities for future studies seeking to improve current LAPC treatment algorithms.

引用

页数：9

共 80 条

[1] Stage III pancreatic cancer and the role of irreversible electroporation [J].

Al Efishat, Mohammad ;

Wolfgang, Christopher L. ;

Weiss, Matthew J. .

BMJ-BRITISH MEDICAL JOURNAL, 2015, 350

[2] Vascular Resections in Association With Pancreatic Resections for Locally Advanced Pancreatic Cancer [J].

Bacalbasa, Nicolae ;

Balescu, Irina ;

Barbu, Ion ;

Stiru, Ovidiu ;

Savu, Cornel ;

Pop, Lucian ;

Al Aloul, Adnan ;

Ursut, Bogdan ;

Brasoveanu, Vladislav ;

Petrea, Sorin .

IN VIVO, 2022, 36 (02) :1001-1006

[3] Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes? A Single Institution's Experience With 118 Patients [J].

Bachellier, Philippe ;

Addeo, Pietro ;

Faitot, Francois ;

Nappo, Gennaro ;

Dufour, Patrick .

ANNALS OF SURGERY, 2020, 271 (05) :932-940

[4] Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline [J].

Balaban, Edward P. ;

Mangu, Pamela B. ;

Khorana, Alok A. ;

Shah, Manish A. ;

Mukherjee, Somnath ;

Crane, Christopher H. ;

Javle, Milind M. ;

Eads, Jennifer R. ;

Allen, Peter ;

Ko, Andrew H. ;

Engebretson, Anitra ;

Herman, Joseph M. ;

Strickler, John H. ;

Benson, Al B., III ;

Urba, Susan ;

Yee, Nelson S. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (22) :2654-U169

[5] Irreversible Electroporation Enhances Delivery of Gemcitabine to Pancreatic Adenocarcinoma [J].

Bhutiani, Neal ;

Agle, Steven ;

Li, Yan ;

Li, Suping ;

Martin, Robert C. G., II .

JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (02) :181-186

[6] Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) [J].

Bockhorn, Maximilian ;

Uzunoglu, Faik G. ;

Adham, Mustapha ;

Imrie, Clem ;

Milicevic, Miroslav ;

Sandberg, Aken A. ;

Asbun, Horacio J. ;

Bassi, Claudio ;

Buechler, Markus ;

Charnley, Richard M. ;

Conlon, Kevin ;

Cruz, Laureano Fernandez ;

Dervenis, Christos ;

Fingerhutt, Abe ;

Friess, Helmut ;

Gouma, Dirk J. ;

Hartwig, Werner ;

Lillemoe, Keith D. ;

Montorsi, Marco ;

Neoptolemos, John P. ;

Shrikhande, Shailesh V. ;

Takaori, Kyoichi ;

Traverso, William ;

Vashist, Yogesh K. ;

Vollmer, Charles ;

Yeo, Charles J. ;

Izbicki, Jakob R. .

SURGERY, 2014, 155 (06) :977-988

[7] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].

Burris, HA ;

Moore, MJ ;

Andersen, J ;

Green, MR ;

Rothenberg, ML ;

Madiano, MR ;

Cripps, MC ;

Portenoy, RK ;

Storniolo, AM ;

Tarassoff, P ;

Nelson, R ;

Dorr, FA ;

Stephens, CD ;

VanHoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413

[8] The promising alliance of anti-cancer electrochemotherapy with immunotherapy [J].

Calvet, Christophe Y. ;

Mir, Lluis M. .

CANCER AND METASTASIS REVIEWS, 2016, 35 (02) :165-177

[9] The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review [J].

Charalambous, Pabos ;

Moris, Dimitrios ;

Karachaliou, Georgia-Sofia ;

Papalampros, Alexandros ;

Dimitrokallis, Nikolaos ;

Tsilimigras, Diamantis, I ;

Oikonomou, Dimitrios ;

Petrou, Athanasios .

EJSO, 2020, 46 (09) :1565-1572

[10] Irreversible electroporation of the pancreas in swine: a pilot study [J].

Charpentier, Kevin P. ;

Wolf, Farrah ;

Noble, Lelia ;

Winn, Brody ;

Resnick, Murray ;

Dupuy, Damian E. .

HPB, 2010, 12 (05) :348-351

← 1 2 3 4 5 6 7 8 →